申请人:Suetsugu Satoshi
公开号:US20120122773A1
公开(公告)日:2012-05-17
The present invention provides a compound of formula (I):
wherein R
1a
is optionally substituted C
1-6
alkyl, etc.; R
1m
is hydrogen atom, etc.; G
1
, G
2
, G
3
and G
4
are (i), etc. ((i) G
1
is —N(R
1b
)—, G
2
is —CO—, G
3
is —C(R
1c
)(R
1d
)—, and G
4
is oxygen, etc.); R
1b
is optionally substituted C
1-6
alkyl, etc.; R
1c
and R
1d
are each independently optionally substituted C
1-6
alkyl, etc.; R
2
is optionally substituted C
1-6
alkyl, etc.; R
3a
, R
3b
, R
3c
and R
3d
are each independently a group: -A-B (A is a single bond, etc., B is hydrogen atom, etc.), etc.; n is 1, etc.; R
5
is C
1-4
alkoxycarbonyl, etc., or a pharmaceutically acceptable salt thereof, which is useful as a renin inhibitor.
本发明提供了一种化合物,其化学式为(I):其中R1a是可选取代的C1-6烷基等;R1m是氢原子等;G1,G2,G3和G4是(i)等,((i) G1是—N(R1b)—,G2是—CO—,G3是—C(R1c)(R1d)—,G4是氧原子等);R1b是可选取代的C1-6烷基等;R1c和R1d分别独立地是可选取代的C1-6烷基等;R2是可选取代的C1-6烷基等;R3a、R3b、R3c和R3d分别独立地是一种基团:-A-B(其中A是单键等,B是氢原子等)等;n是1等;R5是C1-4烷氧羰基等,或其药学上可接受的盐,其作为一种肾素抑制剂是有用的。